Search

everythinglearnresearchcommunity

for

Search:↓

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

Injectable platelet-rich fibrin is a safe and effective treatment for hair loss.

Smoking may worsen hair loss, but more research is needed.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

More plasma leptin means higher baldness risk in men.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

New genes found linked to balding, may help develop future treatments.

Beard hair follicles have more androgen receptors than non-balding scalp hair follicles.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Androgens can both increase and decrease hair growth in different parts of the body.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

The mouse model suggests male pattern baldness may be due to an enzyme increasing DHT and higher androgen receptor levels in hair follicles.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Increased PPARGC1α relates to hair thinning in common baldness.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

Androgens increase a growth factor in hair cells by creating reactive oxygen species, and antioxidants might help treat hair loss.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.